Ensysce Biosciences Balance Sheet (2017-2025) | ENSCW

Balance Sheet Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)
8.01M6.85M12.26M8.44M12.09M4.50M3.15M1.42M3.83M1.46M1.12M3.40M1.04M4.15M3.50M3.05M2.21M1.67M4.31M
Cash & Current Investments (Quarter)
8.01M6.85M12.26M8.44M12.09M4.50M3.15M1.42M3.83M1.46M1.12M3.40M1.04M4.15M3.50M3.05M2.21M1.67M4.31M
Receivables - Net (Quarter)
2.80M10.70M10.70M1.90M1.90M1.60M9.20M9.40M8.90M7.40M
Receivables - Other (Quarter)
0.08M0.09M0.44M0.81M0.28M0.14M0.28M0.29M0.11M0.11M0.10M0.10M0.22M1.78M0.12M0.02M1.20M0.00M0.42M
Receivables (Quarter)
2.88M10.98M10.80M2.00M2.12M1.72M9.22M10.60M8.90M7.82M
Prepaid Assets (Quarter)
0.19M0.18M1.96M0.73M1.79M0.68M0.55M1.85M1.65M0.68M0.01M1.07M1.20M1.19M3.15M1.34M1.33M1.87M1.25M0.11M
Current Assets (Quarter)
0.23M8.36M8.92M15.66M11.66M7.19M7.66M5.30M3.37M5.86M2.76M2.29M4.70M2.46M9.09M5.34M4.40M5.28M2.93M7.25M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
50.000.12M0.12M
Long-Term Investments (Quarter)
12.69M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)
0.84M0.80M0.75M0.71M0.67M0.63M0.59M0.54M0.50M0.46M0.42M0.38M0.34M0.29M0.25M0.21M0.29M0.13M0.08M
Non-Current Assets (Quarter)
12.75M0.84M0.80M0.75M0.71M0.75M0.63M0.59M0.54M0.50M0.46M0.42M0.38M0.34M0.29M0.25M0.21M0.29M0.25M0.21M
Assets (Quarter)
12.98M9.20M9.72M16.42M12.37M7.95M8.29M5.89M3.91M6.36M3.22M2.71M5.07M2.80M9.38M5.60M4.61M5.57M3.18M7.45M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.32M3.14M0.47M0.30M0.96M3.05M1.29M2.94M1.60M1.27M0.92M1.94M0.98M0.48M1.97M1.36M0.62M1.04M0.46M3.27M
Notes Payables (Quarter)
0.47M2.80M12.75M6.07M8.00M8.94M4.41M0.45M0.35M0.85M0.25M0.45M0.39M0.30M0.26M0.42M0.39M0.31M
Payables (Quarter)
0.32M3.61M3.27M13.05M7.03M11.05M10.23M7.35M1.60M1.72M1.27M2.79M1.23M0.94M2.35M1.66M0.87M1.47M0.85M3.57M
Accumulated Expenses (Quarter)
0.41M
Other Accumulated Expenses (Quarter)
0.41M3.73M3.41M1.75M2.67M2.24M2.23M2.36M0.79M0.76M0.54M0.41M0.37M0.45M0.55M0.89M1.05M1.45M0.99M
Short term Debt (Quarter)
0.80M
Current Leases (Quarter)
0.01M0.03M0.02M0.02M0.01M0.04M0.03M0.02M0.01M0.00M
Current Taxes (Quarter)
Total Current Liabilities (Quarter)
0.32M4.03M7.03M16.48M8.80M8.25M11.91M9.46M3.98M2.52M2.03M3.33M1.64M1.31M2.80M2.21M1.76M2.51M2.30M4.57M
Non-Current Liabilities
Non-Current Debt (Quarter)
2.11M3.65M1.59M0.14M1.39M0.14M
Convertible Debt (Quarter)
4.23M16.80M
Non-Current Deffered Revenue (Quarter)
2.00M
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)
-0.24M-0.28M-0.28M-0.28M-0.31M-0.33M-0.32M-0.32M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M-0.33M
Non-Current Deferred Tax Liability (Quarter)
Other Non-Current Liabilities (Quarter)
8.31M0.96M3.65M0.87M0.36M1.41M0.31M0.03M0.01M0.13M0.00M35.00
Total Non-Current Liabilities (Quarter)
2.78M3.07M8.09M2.46M8.39M2.80M0.45M0.09M0.05M0.03M0.03M0.02M0.01M0.00M0.01M0.13M0.00M35.00
Total Liabilities (Quarter)
11.09M4.03M10.10M24.58M11.26M8.75M14.71M9.91M4.07M2.56M2.06M3.36M1.65M1.32M2.80M2.22M1.89M2.51M2.30M4.57M
Shareholder's Equity
Total Debt (Quarter)
2.11M3.65M1.59M0.14M2.19M0.14M
Common Equity (Quarter)
-7.30M5.17M-0.39M-8.16M1.11M-0.80M-6.42M-4.03M-0.15M3.79M1.16M-0.65M3.42M1.48M6.58M3.38M2.72M3.06M1.20M3.21M
Shareholder's Equity (Quarter)
-7.30M5.17M-0.39M-8.16M1.11M-0.80M-6.42M-4.03M-0.15M3.79M1.16M-0.65M3.42M1.48M6.58M3.38M2.72M3.06M1.20M2.88M
Liabilities and Shareholders Equity (Quarter)
12.98M9.20M9.72M16.42M12.37M7.95M8.29M5.89M3.91M6.36M3.22M2.71M5.07M2.80M9.38M5.60M4.61M5.57M3.18M7.45M
Retained Earnings (Quarter)
-2.92M-57.84M-75.00M-85.85M-87.50M-95.51M-105.41M-110.93M-113.13M-115.40M-118.05M-121.56M-124.67M-126.64M-125.98M-129.54M-131.49M-133.22M-136.95M-139.72M
Preferred Shares (Quarter)
3.64M
Treasury Shares (Quarter)
0.02M0.00M691.00377.0063.00